{
    "nctId": "NCT05314114",
    "briefTitle": "Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT",
    "officialTitle": "Selective Omission of Axillary Surgery in Distinct Responders With Triple-negative and HER2-positive Breast Cancer After NACT",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 136,
    "primaryOutcomeMeasure": "ipsilateral axillary recurrence-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Written informed consent\n* Core biopsy confirmed unicentric primary invasive triple-negative or HER2-positive breast cancer. Multifocal or multicentric tumors allowed only if breast-conserving surgery is deemed feasible.\n* At least 18 years of age\n* Initial tumor stage cT1c-T3N0M0 prior to NACT. cN0 stage established by clinical examination and ultrasonography\n* In cases with suspicious lymph node, a negative core biopsy or fine needle aspiration (FNA) biopsy of the sonographically suspected lymph node is required\n* Standard NACT with evident radiologic response\n* Planned breast-conserving surgery with postoperative external whole-breast irradiation\n\nExclusion Criteria:\n\n* History of previous malignancy\n* Histologically proven N1 patients, patients with distant metastasis (M1)\n* Pregnant or lactating patients\n* Inflammatory breast cancer\n* Radiologically non-responsive after NACT\n* Mastectomy planned after NACT\n* planned intraoperative radiotherapy (e.g. Intrabeam) or postoperative partial breast irradiation (e.g. multicatheter technique) alone; both procedures are allowed as boost techniques\n* Written informed consent not obtained",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}